Inhibition of splicing by serine-arginine rich protein 55 (SRp55) causes the appearance of partially spliced HIV-1 mRNAs in the cytoplasm

Virus Research

Volumn 157, Issue 1, 2011, Pages 82-91

  Tranell, Anna ^a   Tingsborg, Susanne ^a   Fenyö, Eva Maria ^b   Schwartz, Stefan ^a,b,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

HIV 1; Splicing; SRp55; Vpr

Indexed keywords

ARGININE; MESSENGER RNA; SERINE; SERINE ARGININE RICH PROTEIN 55; UNCLASSIFIED DRUG;

ARTICLE; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROVIRUS; RNA SPLICING;

CELLS, CULTURED; CYTOPLASM; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; EXONS; GENOME, VIRAL; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PLASMIDS; PROVIRUSES; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING; RNA, MESSENGER; RNA, VIRAL; VIRAL REGULATORY AND ACCESSORY PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79953024872     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.02.010     Document Type: Article

References (57)

1. Amendt B.A., Hesslein D., Chang L.J., Stoltzfus C.M. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Molecular and Cellular Biology 1994, 14(6):3960-3970.
2. Amendt B.A., Si Z.H., Stoltzfus C.M. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Molecular and Cellular Biology 1995, 15(11):6480.
3. Arrigo S.J., Weitsman S., Zack J.A., Chen I.S. Characterization and expression of novel singly spliced RNA species of human immunodeficiency virus type 1. Journal of Virology 1990, 64(9):4585-4588.
4. Arya S.K., Gallo R.C. Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients. Proceedings of the National Academy of Sciences of the United States of America 1986, 83(7):2209-2213.
5. Bilodeau P.S., Domsic J.K., Mayeda A., Krainer A.R., Stoltzfus C.M. RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element. Journal of Virology 2001, 75(18):8487-8497.
6. Björk P., Jin S., Zhao J., Singh O.P., Persson J.-O., Hellman U., Wieslander L. Specific combinations of SR proteins associate with single pre-messenger RNAs in vivo and contribute different functions. Journal of Cell Biology 2009, 184:555-568.
7. Caceres J.F., Krainer A.R. Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains. The EMBO Journal 1993, 12(12):4715-4726.
8. Caceres J.F., Screaton G.R., Krainer A.R. A specific subset of SR proteins shuttles continuously between the mucleus and the cytoplasm. Genes & development 1998, 12:55-66.
9. Caceres J.F., Stamm S., Helfman D.M., Krainer A.R. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science (New York, N. Y.) 1994, 265(5179):1706-1709.
10. Caputi M., Freund M., Kammler S., Asang C., Schaal H. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression. Journal of Virology 2004, 78(12):6517-6526.
11. Chang D.D, Sharp P.A. Regulation by HIV Rev depends upon recognition of splice sites. Cell 1989, 95:789-795.
12. Collier B., Oberg D., Zhao X., Schwartz S. Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells. Journal of Virology 2002, 76(6):2739-2752.
13. Dyhr-Mikkelsen H., Kjems J. Inefficient spliceosome assembly and abnormal branch site selection in splicing of an HIV-1 transcript in vitro. The Journal of Biological Chemistry 1995, 270(41):24060-24066.
14. Escudero-Paunetto L., Li L., Hernandez F.P., Sandri-Goldin R.M. SR proteins SRp20 an 9G8 contribute to effeicient export of herpes simplex virus mRNAs. Virology 2010, 401:155-164.
15. Fujita M., Otsuka M., Nomaguchi M., Adachi A. Multifaceted activity of HIV Vpr/Vpx proteins: the current view of thier virological functions. Reviews in Medical Virology 2010, 20:68-76.
16. Guatelli J.C., Gingeras T.R., Richman D.D. Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells. Journal of Virology 1990, 64(9):4093-4098.
17. Hargous Y., Hautbergue G.M., Tintaru A.M., Skrisovska L., Golovanov A.P., Stevenin J., Lian L.Y., Wilson S.A., Allain F.H. Molecular basis of RNA recognition and TAP binding by the SR proteins SRp20 and 9G8. The EMBO Journal 2006, 25(21):5126-5137.
18. Huang Y., Gattoni R., Stevenin J., Steitz J.A. SR splicing factors serve as adapter proteins for TAP-dependent mRNA export. Molecular Cell 2003, 11(3):837-843.
19. Huang Y., Steitz J.A. Splicing factors SRp20 and 9G8 promote the nucleocytoplasmic export of mRNA. Molecular Cell 2001, 7:899-905.
20. Jablonski J.A., Caputi M. Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity. Journal of Virology 2009, 83(2):981-992.
21. Jacquenet S, Decimo D., Muriaux D., Darlix J.L. Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production. Retrovirology 2005, 2:33.
22. Jacquenet S., Mereau A., Bilodeau P.S., Damier L., Stoltzfus C.M., Branlant C. A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H. The Journal of Biological Chemistry 2001, 276(44):40464-40475.
23. Kammler S., Leurs C., Freund M., Krummheuer J., Seidel K., Tange T.O., Lund M.K., Kjems J., Scheid A., Schaal H. The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA. RNA (New York, N. Y.) 2001, 7(3):421-434.
24. Kilareski E.M., Shah S., Nonnemacher M.R., Wigdahl B. Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage. Retrovirology 2009, 6:1-24.
25. Lai M.C., Tarn W.Y. Hypophosphorylated ASF/SF2 binds TAP and is present in messenger ribonucleoproteins. The Journal of Biological Chemistry 2004, 279:31745-31749.
26. Long J.C., Caceres J.F. The SR protein family of splicing factors: master regulators of gene expression. The Biochemical Journal 2009, 417(1):15-27.
27. Madsen J.M., Stoltzfus C.M. An exonic splicing silencer downstream of the 3' splice site A2 is required for efficient human immunodeficiency virus type 1 replication. Journal of Virology 2005, 79(16):10478-10486.
28. Maldarelli F., Xiang C., Chamoun G., Zeichner S.L. The expression of the essential nuclear splicing factor SC35 is altered by human immunodeficiency virus infection. Virus Research 1998, 53(1):39-51.
29. Malim M.H., Emerman M. HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell host & Microbe 2008, 3(6):388-398.
30. Marchand V., Mereau A., Jacquenet S., Thomas D., Mougin A., Gattoni R., Stevenin J., Branlant C. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding. Journal of Molecular Biology 2002, 323(4):629-652.
31. Mermer B., Felber B.K., Campbell M., Pavlakis G.N. Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells. Nucleic Acids Research 1990, 18:2037-2044.
32. Nasioulas G., Zolotukhin A.S., Tabernero C., Solomin L., Cunningham C.P., Pavlakis G.N., Felber B.K. Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA. Journal of Virology 1994, 68:2986-2993.
33. O'Reilly M.M., McNally M.T., Beemon K.L. Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA. Virology 1995, 213(2):373-385.
34. Ote I., Lebrun M., Vandevenne P., Bontems S., Medina-Palazon C., Manet E., Piete J., Sadzot-Delvaux C. Varicella-Zoster virus IE4 protein interacts with SR proteins and exports mRNAs through the TAP/NXF1 pathway. PLoS ONE 2009, 4(11):1-13.
35. Purcell D.F., Martin M.A. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. Journal of Virology 1993, 67(11):6365-6378.
36. Romani B, Engelbrecht S. HIV-1 Vpr: functions and molecular interactions. The Journal of General Virology 2009, 90:1795-1806.
37. Ropers D., Ayadi L., Gattoni R., Jacquenet S., Damier L., Branlant C., Stevenin J. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA. The Journal of Biological Chemistry 2004, 279(29):29963-29973.
38. Sapra A.K., Änkö M.-L., Grishina I., Lorenz M., Pabis M., Poser I., Rollins J., Weiland E.-M., Neugebauer K.M. SR protein family members display diverse activities in the formation of nascent and mature mRNPs in vivo. Molecular Cell 2009, 34:179-190.
39. Schwartz S., Felber B.K., Benko D.M., Fenyo E.M., Pavlakis G.N. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. Journal of Virology 1990, 64(6):2519-2529.
40. Schwartz S., Felber B.K., Fenyo E.M., Pavlakis G.N. Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. Journal of Virology 1990, 64(11):5448-5456.
41. Schwartz S., Felber B.K., Pavlakis G.N. Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing. Virology 1991, 183(2):677-686.
42. Schwartz S., Felber B.K., Pavlakis G.N. Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs. Molecular and Cellular Biology 1992, 12(1):207-219.
43. Screaton G.R., Caceres J.F., Mayeda A., Bell M.V., Plebanski M., Jackson D.G., Bell J.I., Krainer A.R. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. The EMBO Journal 1995, 14(17):4336-4349.
44. Si Z., Amendt B.A., Stoltzfus C.M. Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2. Nucleic Acids Research 1997, 25(4):861-867.
45. Si Z.H., Rauch D., Stoltzfus C.M. The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly. Molecular and Cellular Biology 1998, 18(9):5404-5413.
46. Soret J., Bakkour N., Maire S., Durand S., Zekri L., Gabut M., Fic W., Divita G., Rivalle C., Dauzonne D., Nguyen C.H., Jeanteur P., Tazi J. Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(24):8764-8769.
47. Staffa A., Cochrane A. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Molecular and Cellular Biology 1995, 15(8):4597-4605.
48. Stoltzfus C.M., Madsen J.M. Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing. Current HIV Research 2006, 4(1):43-55.
49. Sundqvist V.A., Albert J., Ohlsson E., Hinkula J., Fenyö E.M., Wahren B. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. Journal of Medical Virology 1989, 29:170-175.
50. Swanson C.M., Sherer N.M., Malim M.H. SRp40 and SRp55 promote the translation of unspliced human immunodeficiency virus type 1 RNA. Journal of Virology 2010, 84:6748-6759.
51. Tan W., Felber B.K., Zolotukhin A.S., Pavlakis G.N., Schwartz S. Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1. Journal of Virology 1995, 69(9):5607-5620.
52. Tange T.O., Damgaard C.K., Guth S., Valcarcel J., Kjems J. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element. The EMBO Journal 2001, 20(20):5748-5758.
53. Tranell A., Fenyö E.M., Schwartz S. SRp55 and SRp75 induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3. The Journal of Biological Chemistry 2010 August, (Epub ahead of print).
54. Valencia P., Dias A.P., Reed R. Splicing promotes radpid and efficint mRNA export in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:3386-3391.
55. Wiklund L., Sokolowski M., Carlsson A., Rush M., Schwartz S. Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability element in the HPV-1 late 3' untranslated region. The Journal of Biological Chemistry 2002, 277(43):40462-40471.
56. Zahler A.M., Damgaard C.K., Kjems J., Caputi M. SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing. The Journal of Biological Chemistry 2004, 279(11):10077-10084.
57. Zhao X., Rush M., Schwartz S. Identification of an hnRNP A1 dependent splicing silencer in the HPV-16 L1 coding region that prevents premature expression of the late L1 gene. Journal of Virology 2004, 78:10888-10905.